Total Neoadjuvant Treatment Combined With Adaptive Radiotherapy for Rectal Cancer

Diarrhea was the most frequently reported severe adverse event in the treatment regime of pre-operative sequential short-course radiotherapy followed by chemotherapy (so called total neo-adjuvant treatment). This study therefore investigates the benefit of on-couch adaptation for locally advanced rectal cancer patients undergoing this treatment regime.

Trial Details

NCT ID
NCT05883800
Phase
NA
Sponsor
Haukeland University Hospital
Status
RECRUITING
Cancer Type
Colorectal Cancer
Interventions
  • On-couch adaptive radiotherapy
Locations (sample)
  • Bergen, Norway|60.39299,5.32415

Key Eligibility Criteria

  • Patients with loco-regional advanced rectal adenocarcinoma with clinical indications for short-course with TNT chemotherapy i.e. having at least on…
  • ECOG status ≤ 1
  • Being willing and able to give full written consent for participation

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Colorectal Cancer Trials on Trialify →